GGrantIndex
Sort

51,593 grants matching hepatitis

Metabolic Regulation in the Acute Phase

$457,265
Hyung D Ryoo · New York University School Of Medicine · R01 · FY2010 · DK

Screening for fibroblast-selective inhibitors of YAP/TAZ

$457,250
Daniel J. Tschumperlin · Mayo Clinic Rochester · R56 · FY2018 · AG

Harnessing the power of peer navigation and mHealth to reduce health disparities in Appalachia

$457,228
Scott D Rhodes · Wake Forest University Health Sciences · R01 · FY2021 · NR

Hepatic steatosis promotes liver metastasis

$457,219
Steven L Teitelbaum · Washington University · R01 · FY2022 · CA

Type 1 IFN Function and Signaling in Immunity to Viruses

$457,210
Christine A Biron · Brown University · R56 · FY2009 · AI

Evaluating HIV expression and latency in blood and tissues at the single cell level

$457,171
Joseph K. Wong · Northern California Institute/Res/Edu · R33 · FY2017 · AI

Sympathetic circadian dysfunction in obesity-related hepatocarcinogenesis

$457,161
Loning None Fu · Baylor College Of Medicine · R01 · FY2021 · CA

International Collaborative of prospective studies of HIV and Hepatitis in IDU

$457,155
Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2014 · DA

Immunologic and Virologic Correlates of the Age-Related Decrease in HBV DNA in Children

$457,153
Kathleen Schwarz · Johns Hopkins University · U01 · FY2018 · DK

Dissecting virus neutralizing determinants to guide HCV vaccine development

$457,124
Mansun Law · Scripps Research Institute, The · R01 · FY2017 · AI

Epigenetic regulation in liver fibrosis

$457,057
Xiaocheng Charlie Dong · Indiana University Indianapolis · R01 · FY2020 · DK

Epigenetic regulation in liver fibrosis

$457,057
Xiaocheng Charlie Dong · Indiana University Indianapolis · R01 · FY2022 · DK

Epigenetic regulation in liver fibrosis

$457,057
Xiaocheng Charlie Dong · Indiana University Indianapolis · R01 · FY2023 · DK

Epigenetic regulation in liver fibrosis

$457,057
Xiaocheng Charlie Dong · Indiana University Indianapolis · R01 · FY2021 · DK

Mechanisms of naturally-acquired immunity to malaria

$457,038
Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

MECHANISMS AND STRATEGIES FOR INSULIN RESISTANCE IN AIDS

$457,023
Massachusetts General Hospital · R01 · FY2000 · DK

Immune Response to RBC Antigens

$457,000
Krystalyn E Hudson · Bloodworks · R01 · FY2017 · HL

Investigation of the mechanism by which NPC1 dysfunction leads to liver disease

$456,992
Laura Liscum · Tufts University Boston · R01 · FY2010 · DK

HDL GENE DISCOVERY--GENOME WIDE EXPRESSION SCREENS

$456,989
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2002 · HL

1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA

$456,829
Margaret May · University Of Bristol · U01 · FY2017 · AA

IN UTERO SMALL AND LARGE ANIMAL RESOURCE CORE

$456,737
Alan W. Flake · Children'S Hosp Of Philadelphia · U19 · FY2025 · NS

Characterization of the role of neuropeptide VIP-mediated fucosylation in alcohol associated liver disease

$456,719
Zhong-Bin Deng · University Of Louisville · R01 · FY2024 · AA

3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)

$456,698
Mari M Kitahata · University Of Washington · U01 · FY2011 · AA

Iron Deficiency and Anemia in HIV and HCV-Infected Women

$456,651
Johns Hopkins University · R01 · FY2004 · DA

Molecular Basis of a New Form of Hyperinsulinism

$456,624
Charles Alfred Stanley · Children'S Hosp Of Philadelphia · R01 · FY2008 · DK